Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NeuroPace IncNPCE · Entity 5459 | Director | June 13, 2022 | June 22, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NeuroPace Inc
Report date June 13, 2022 · Filed June 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.30 · Expires 2032-06-12 | Direct | 18,253 |
Reported balance
After 2022-06-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-13 · Grant · Acquired 18,253 · Balance 18,253 F1: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2022 Filed Jun 22, 2022 01:12 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 18,253 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001209191-22-038612 · doc4.xml · derivative · entry 1 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,253 Underlying: Common Stock · 18,253 shares Expires 2032-06-12 F1 · derivative.exercise_date: The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:17 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionSeries B' Preferred Stock · Derivative | 5,271,902 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028325 · doc4.xml · derivative · entry 6 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 5,271,902 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F3 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F2 · ownership.nature: KCK Ltd. has sole voting and investment power with respect to the shares. The board of directors of KCK Ltd., consisting of Antoine Sacy, Kamal Kassar, and Nael Karim Kassar, has delegated its authority to vote or invest the shares to Nael Karim Kassar. As such, Nael Karim Kassar may also be deemed to have sole voting and investment with respect to the shares. Mr. Kassar and Greg Garfield, who serves as Senior Managing Director with KCK-US, Inc., an affiliate of KCK Ltd., are also members of our board of directors. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:17 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionSeries A' Preferred Stock · Derivative | 323,591 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028325 · doc4.xml · derivative · entry 5 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 324,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F3 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F2 · ownership.nature: KCK Ltd. has sole voting and investment power with respect to the shares. The board of directors of KCK Ltd., consisting of Antoine Sacy, Kamal Kassar, and Nael Karim Kassar, has delegated its authority to vote or invest the shares to Nael Karim Kassar. As such, Nael Karim Kassar may also be deemed to have sole voting and investment with respect to the shares. Mr. Kassar and Greg Garfield, who serves as Senior Managing Director with KCK-US, Inc., an affiliate of KCK Ltd., are also members of our board of directors. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:17 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionSeries B' Preferred Stock · Derivative | 18,032 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028325 · doc4.xml · derivative · entry 4 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 18,032 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F3 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F1 · ownership.nature: Shares are held by the Greg and Dori Garfield Living Revocable Trust. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:17 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionSeries A' Preferred Stock · Derivative | 859 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028325 · doc4.xml · derivative · entry 3 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 859 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F3 · derivative.expiration_date: Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date. F1 · ownership.nature: Shares are held by the Greg and Dori Garfield Living Revocable Trust. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:17 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionCommon Stock | 5,595,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028325 · doc4.xml · nonDerivative · entry 2 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,614,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: KCK Ltd. has sole voting and investment power with respect to the shares. The board of directors of KCK Ltd., consisting of Antoine Sacy, Kamal Kassar, and Nael Karim Kassar, has delegated its authority to vote or invest the shares to Nael Karim Kassar. As such, Nael Karim Kassar may also be deemed to have sole voting and investment with respect to the shares. Mr. Kassar and Greg Garfield, who serves as Senior Managing Director with KCK-US, Inc., an affiliate of KCK Ltd., are also members of our board of directors. Read SEC document |
| April 26, 2021 Filed Apr 26, 2021 21:17 UTC | NeuroPace Inc NPCE · Entity 5459 | ConversionCommon Stock | 18,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028325 · doc4.xml · nonDerivative · entry 1 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares are held by the Greg and Dori Garfield Living Revocable Trust. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 23:27 UTC | NeuroPace Inc NPCE · Entity 5459 | GrantStock Option (Right to Buy) · Derivative | 21,698 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001209191-21-028189 · doc4.xml · derivative · entry 2 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,698 Underlying: Common Stock · 21,698 shares Expires 2031-04-20 F2 · derivative.exercise_date: 1/36th of the shares subject to the option vest in equal monthly installments commencing May 21, 2021. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 23:27 UTC | NeuroPace Inc NPCE · Entity 5459 | PurchaseCommon Stock | 13,235 | $17.00 | $224,995.00 |
DisclosureSEC source: 0001209191-21-028189 · doc4.xml · nonDerivative · entry 1 Garfield Greg Shaw · CIK 0001594406 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,853 F1 · shares: Reflects shares purchased from the underwriters in the Companys initial public offering. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.